|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 184.30 SEK | -2.85% |
|
-0.86% | -7.62% |
| 17/06 | Lannebo Sverige Plus increased by 4.3 percent in May – rising profitability at Elekta | FW |
| 13/06 | BioArctic to Advance Parkinson's Disease Drug Trial After Positive Safety Review | MT |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Biological Products | ||||||||||
Biotechnology | 6.52Cr | 2.57Cr | 23Cr | 62Cr | 26Cr | |||||
Total Assets | 105.03Cr | 90Cr | 86Cr | 118.61Cr | 111.17Cr | |||||
Interest Expense | -10.98L | -8L | -6L | -3L | - | |||||
Income Tax Expense | -1.82Cr | -2.07Cr | 11T | 4.72Cr | -1.24Cr | |||||
CAPEX | -1.25Cr | -43.86L | -1.27Cr | -74.43L | -2.66Cr | |||||
EBT | -8.67Cr | -14Cr | -1.12Cr | 28Cr | -19Cr | |||||
Gross Profit | - | - | - | - | 23Cr | |||||
D&A | 1.1Cr | 1.35Cr | 1.42Cr | 74.39L | 1.07Cr | |||||
Operating Income | -8.5Cr | -14Cr | -1.74Cr | 25Cr | -23Cr | |||||
Net Income | -6.85Cr | -12Cr | -1.12Cr | 23Cr | -18Cr |
Geographical Revenue Distribution History
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
North America | - | - | - | - | 14Cr | |||||
Asia | 2.85Cr | 1.47Cr | 17Cr | 62Cr | 10Cr | |||||
Europe | 3.38Cr | 84.66L | 5.85Cr | - | 1.17Cr | |||||
Rest of World | - | - | - | - | 47T |
- Stock Market
- Equities
- BIOA B Stock
- Financials BioArctic AB
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition